Polymorphisms in thymidylate synthase gene and susceptibility to breast cancer in a Chinese population: a case-control analysis

[1]  K. Matsuo,et al.  One-carbon metabolism related gene polymorphisms interact with alcohol drinking to influence the risk of colorectal cancer in Japan. , 2005, Carcinogenesis.

[2]  Hongbing Shen,et al.  Polymorphisms of thymidylate synthase in the 5'- and 3'-untranslated regions associated with risk of gastric cancer in South China: a case-control analysis. , 2005, Carcinogenesis.

[3]  Z. Fan,et al.  Association of methylenetetrahydrofolate reductase and thymidylate synthase promoter polymorphisms with genetic susceptibility to esophageal and cardia cancer in a Chinese high-risk population. , 2005, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[4]  W. Tan,et al.  Significant increase in risk of gastroesophageal cancer is associated with interaction between promoter polymorphisms in thymidylate synthase and serum folate status. , 2005, Carcinogenesis.

[5]  Chien-Jen Chen,et al.  Evaluation of Risk Factors for Nasopharyngeal Carcinoma in High-Risk Nasopharyngeal Carcinoma Families in Taiwan , 2005, Cancer Epidemiology Biomarkers & Prevention.

[6]  Qiuling Shi,et al.  Case-control analysis of thymidylate synthase polymorphisms and risk of lung cancer. , 2004, Carcinogenesis.

[7]  Jacques Ferlay,et al.  Estimates of cancer incidence in China for 2000 and projections for 2005. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[8]  T. Merriman,et al.  Association of thymidylate synthase polymorphisms with gastric cancer susceptibility , 2004, International journal of cancer.

[9]  W. Guo,et al.  Association of the thymidylate synthase polymorphisms with esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma. , 2004, Carcinogenesis.

[10]  M. Spitz,et al.  Thymidylate Synthase 5′- and 3′-Untranslated Region Polymorphisms Associated with Risk and Progression of Squamous Cell Carcinoma of the Head and Neck , 2004, Clinical Cancer Research.

[11]  J. Beilby,et al.  Methylenetetrahydrofolate reductase and thymidylate synthase polymorphisms are not associated with breast cancer risk or phenotype. , 2004, Anticancer research.

[12]  S. Groshen,et al.  A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels. , 2004, Pharmacogenetics.

[13]  J. Little,et al.  Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. , 2004, American journal of epidemiology.

[14]  Peter Donnelly,et al.  A comparison of bayesian methods for haplotype reconstruction from population genotype data. , 2003, American journal of human genetics.

[15]  Rebecca A Mosig,et al.  Polymorphism in the thymidylate synthase promoter enhancer region modifies the risk and survival of colorectal cancer. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[16]  S. Miyoshi,et al.  New prognostic indicator for non‐small‐cell lung cancer, quantitation of thymidylate synthase by real‐time reverse transcription polymerase chain reaction , 2003, International journal of cancer.

[17]  W. Willett,et al.  Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. , 2003, Journal of the National Cancer Institute.

[18]  K. Matsuo,et al.  Associations between polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and susceptibility to malignant lymphoma. , 2003, Haematologica.

[19]  C. Ulrich,et al.  Thymidylate synthase promoter polymorphism, interaction with folate intake, and risk of colorectal adenomas. , 2002, Cancer research.

[20]  G. Morgan,et al.  Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. , 2002, Blood.

[21]  J. Potter,et al.  Dietary folate intake and breast cancer risk: results from the Shanghai Breast Cancer Study. , 2001, Cancer research.

[22]  J. Cerhan,et al.  Dietary Folate Intake, Alcohol, and Risk of Breast Cancer in a Prospective Study of Postmenopausal Women , 2001, Epidemiology.

[23]  B. Ames,et al.  DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. , 2001, Mutation research.

[24]  C. Ulrich,et al.  Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[25]  A. Miller,et al.  Dietary folate consumption and breast cancer risk. , 2000, Journal of the National Cancer Institute.

[26]  K. Kawakami,et al.  Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers. , 1999, Anticancer research.

[27]  H. McLeod,et al.  Ethnic variation in the thymidylate synthase enhancer region polymorphism among Caucasian and Asian populations. , 1999, Genomics.

[28]  Y. Kim,et al.  Folate and carcinogenesis: evidence, mechanisms, and implications. , 1999, The Journal of nutritional biochemistry.

[29]  S. Duthie,et al.  Folic acid deficiency and cancer: mechanisms of DNA instability. , 1999, British medical bulletin.

[30]  A. Giuliano,et al.  Hypomethylation in cervical tissue: is there a correlation with folate status? , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[31]  B. Ames,et al.  Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Yin,et al.  Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  J. Mason,et al.  Folate: effects on carcinogenesis and the potential for cancer chemoprevention. , 1996, Oncology.

[34]  N. Horie,et al.  Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5'-terminal regulatory region of the human gene for thymidylate synthase. , 1995, Cell structure and function.

[35]  L. Poirier,et al.  Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats. , 1995, Cancer research.

[36]  T. Seno,et al.  Chromosome breakage induced by thymidylate stress in thymidylate synthase-negative mutants of mouse FM3A cells. , 1984, Cancer research.